About Peroxisomal membrane protein 2
Peroxisomal membrane protein 2 (PXMP2) is a protein
from Homo sapiens identified by UniProt accession
Q9NR77, 195 residues long.
MolForge cross-references it against 0 known binders and
35 disease associations.
Target properties
| Protein name | Peroxisomal membrane protein 2 |
| UniProt accession | Q9NR77 |
| Gene | PXMP2 |
| Organism | Homo sapiens |
| Length | 195 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (35)
Diseases linked to this target (Open Targets).
- mean corpuscular hemoglobin · score 0.25
- mean corpuscular hemoglobin concentration · score 0.19
- reticulocyte measurement · score 0.19
- Red cell distribution width · score 0.18
- health study participation · score 0.13
- colorectal cancer, susceptibility to, 12 · score 0.12
- facial dysmorphism-immunodeficiency-livedo-short stature syndrome · score 0.12
- intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency · score 0.12
- Facial dysmorphism - immunodeficiency - livedo - short stature · score 0.12
- mean corpuscular volume · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NR77-F1 | alphafold | PREDICTED | 85.15 | — |
Amino-acid sequence (195 residues)
MAPAASRLRA EAGLGALPRR ALAQYLLFLR LYPVLTKAAT SGILSALGNF LAQMIEKKRK KENSRSLDVG GPLRYAVYGF FFTGPLSHFF YFFMEHWIPP EVPLAGLRRL LLDRLVFAPA FLMLFFLIMN FLEGKDASAF AAKMRGGFWP ALRMNWRVWT PLQFININYV PLKFRVLFAN LAALFWYAYL ASLGK
Explore Peroxisomal membrane protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets